RBC boosting drugs may undermine breast cancer treatment with Herceptin

[News]

Red-blood-cell-boosting drugs used to treat anemia may undermine breast cancer treatment with Herceptin, a targeted therapy that blocks the cancer-promoting HER2 protein, researchers from The University of Texas MD Anderson Cancer Center report in the Nov. 16 edition of Cancer Cell.

More... (http://www.news-medical.net/news/20101116/RBC-boosting-drugs-may-undermine-breast-cancer-treatment-with-Herceptin.aspx)